CTSO logo

Cytosorbents (CTSO)

Profile

Full Name

Cytosorbents Corporation

Ticker Symbol

NASDAQ: CTSO

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

August 8, 2006

Indexes

Not included

Website

http://www.cytosorbents.com

Employees

149

Key Details

Price

$1.09(+9.00%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$35.59M(+14.51% YoY)

Annual EPS

-$0.38(+41.54% YoY)

PE ratio

-

Next earnings date

Aug 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.09
    CTSO price is $1.09

    30-Day Relative Volume

    1.66
    CTSO 30-day relative volume is 1.66

    Price Performance

    Price Most recent change

    +9%
    CTSO price was up +9% on Jul 3, 2025

    Price YTD change

    +19.78%
    CTSO price is up +19.78% since January 1st

    Price 1-year change

    +26.74%
    CTSO price is up +26.74% year-on-year

    Price 3-year change

    -45.77%
    CTSO price is down -45.77% over the past 3 years

    Price Range

    Price All-time high

    $98.75
    CTSO price is currently -98.90% below its historical high of $98.75

    Price 3-year low

    $0.70
    CTSO price is currently +55.71% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $68.25M
    CTSO market capitalization is $68.25 million

    Market cap 3-year change

    -22.47%
    CTSO market capitalization is down -22.47% over the past 3 years

    Market cap All-time high

    $498.66M
    CTSO market capitalization is currently -86.31% below its historical high of $498.66 million

    Market cap sector rank

    39.54%
    CTSO market capitalization is higher than 39.54% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +14.72%
    CTSO shares outstanding is up +14.72% year-on-year

    Shares Outstanding 3-Year Change

    +42.97%
    CTSO shares outstanding is up +42.97% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.49
    CTSO beta is 0.49

    200-day SMA

    $1.04
    CTSO price is currently +5.19% above its 200-day simple moving average

    50-day SMA

    $1.01
    CTSO price is currently +7.64% above its 50-day simple moving average

    RSI

    48.92
    CTSO 14-day relative strength index is 48.92

    Volume

    1.66
    CTSO 30-day relative volume is 1.66

    ATR

    $0.12
    CTSO average true range is $0.12

    10-day Historical Volatility

    139.53%
    CTSO 10-day historical volatility is 139.53%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $35.59M
    CTSO annual revenue is $35.59 million

    Revenue Analysts estimate

    $41.15M
    CTSO annual revenue is currently -13.49% lower than the consensus analysts' forecast

    Revenue 1-year change

    +14.51%
    CTSO annual revenue is up +14.51% year-on-year

    Revenue Sector rank

    42.24%
    CTSO annual revenue is higher than 42.24% of companies in Healthcare sector

    EPS

    EPS

    -$0.38
    CTSO annual earnings per share is -$0.38

    EPS Analysts estimate

    -
    CTSO annual earnings per share consensus analysts' forecast is unknown

    EPS 1-year change

    +41.54%
    CTSO annual earnings per share is up +41.54% year-on-year

    EPS Sector rank

    70.9%
    CTSO annual earnings per share is higher than 70.9% of companies in Healthcare sector

    Profit

    Gross profit

    $25.13M
    CTSO annual gross profit is $25.13 million

    Gross margin

    70.59%
    CTSO annual gross profit margin is 70.59%

    Operating profit

    -$16.79M
    CTSO annual operating income is -$16.79 million

    Operating margin

    -47.16%
    CTSO annual operating profit margin is -47.16%

    Net income

    -$20.72M
    CTSO annual net profit is -$20.72 million

    Net margin

    -58.21%
    CTSO annual net profit margin is -58.21%

    Expenses

    Total expenses

    $52.38M
    CTSO annual total expenses is $52.38 million

    Operating expenses

    $41.91M
    CTSO annual total operating expenses is $41.91 million

    Cost of goods sold

    $10.47M
    CTSO annual cost of goods sold is $10.47 million

    Selling, general & administrative expenses

    $35.00M
    CTSO annual SGA is $35.00 million

    Depreciation and amortization

    $1.74M
    CTSO annual depreciation & amortization is $1.74 million

    Interest expense

    $1.40M
    CTSO annual interest expense is $1.40 million

    Income tax

    -$1.69M
    CTSO annual income tax is -$1.69 million

    EBIT & EBITDA

    EBIT

    -$21.01M
    CTSO annual earnings before interest & taxes is -$21.01 million

    EBITDA

    -$19.27M
    CTSO annual EBITDA is -$19.27 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $47.37M
    CTSO annual total assets is $47.37 million

    Non current assets

    $25.77M
    CTSO annual long term assets is $25.77 million

    Current assets

    $21.60M
    CTSO annual total current assets is $21.60 million

    Cash and cash equivalents

    $3.28M
    CTSO annual cash & cash equivalents is $3.28 million

    Accounts receivable

    $7.32M
    CTSO annual accounts receivable is $7.32 million

    Inventory

    $2.73M
    CTSO annual inventory is $2.73 million

    Liabilities

    Total liabilities

    $36.26M
    CTSO annual total liabilities is $36.26 million

    Long term liabilities

    $26.44M
    CTSO annual total long term liabilities is $26.44 million

    Current liabilities

    $9.82M
    CTSO annual total current liabilities is $9.82 million

    Accounts payable

    $3.34M
    CTSO annual accounts payable is $3.34 million

    Debt

    Total debt

    $26.89M
    CTSO annual total debt is $26.89 million

    Total debt 1-year change

    +46.85%
    CTSO annual total debt is up +46.85% year-on-year

    Long term debt

    $26.44M
    CTSO annual long term debt is $26.44 million

    Short term debt

    $452.70K
    CTSO annual short term debt is $452.70 thousand

    Equity & Capital

    Shareholders equity

    $11.11M
    CTSO annual stockholders equity is $11.11 million

    Book value

    $11.11M
    CTSO annual book value is $11.11 million

    Retained earnings

    -$304.01M
    CTSO annual retained earnings is -$304.01 million

    Working capital

    $11.78M
    CTSO annual working capital is $11.78 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$14.43M
    CTSO annual cash flow from operations is -$14.43 million

    Cash from operations 1-year change

    +33.37%
    CTSO annual cash flow from operations is up +33.37% year-on-year

    Cash from investing

    -$669.40K
    CTSO annual cash flow from investing activities is -$669.40 thousand

    Cash from investing 1-year change

    +28.5%
    CTSO annual cash flow from investing activities is up +28.5% year-on-year

    Cash from financing

    $9.33M
    CTSO annual cash flow from financing activities is $9.33 million

    Cash from financing 1-year change

    -35.54%
    CTSO annual cash flow from financing activities is down -35.54% year-on-year

    CAPEX

    CAPEX

    $669.40K
    CTSO annual capital expenditures is $669.40 thousand

    CAPEX 1-year change

    -28.5%
    CTSO annual capital expenditures is down -28.5% year-on-year

    Free Cash Flow

    Free cash flow

    -$15.10M
    CTSO annual free cash flow is -$15.10 million

    Free cash flow 1-year change

    +33.17%
    CTSO annual free cash flow is up +33.17% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    70.59%
    CTSO annual gross profit margin is 70.59%

    Operating margin

    -47.16%
    CTSO annual operating profit margin is -47.16%

    Net margin

    -58.21%
    CTSO annual net profit margin is -58.21%

    ROA & ROE

    ROA

    -41.30%
    CTSO annual return on assets is -41.30%

    ROE

    -119.80%
    CTSO annual return on equity is -119.80%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    CTSO price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    CTSO price to earnings ratio is unknown

    PB Ratio

    PB ratio

    4.69
    CTSO price to book ratio is 4.69

    PB ratio Sector rank

    79.06%
    CTSO price to book ratio is higher than 79.06% of companies in Healthcare sector

    PS Ratio

    PS ratio

    1.93
    CTSO price to sales ratio is 1.93

    PS ratio Sector rank

    38.81%
    CTSO price to sales ratio is higher than 38.81% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $83.63M
    CTSO enterprise value is $83.63 million

    Enterprise value Sector rank

    43.18%
    CTSO enterprise value is higher than 43.18% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -6.30
    CTSO EV/EBITDA is -6.30

    EV/EBITDA Sector rank

    20.09%
    CTSO EV/EBITDA is higher than 20.09% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    2.20
    CTSO annual current ratio is 2.20

    Quick ratio

    1.92
    CTSO annual quick ratio is 1.92

    Leverage

    Debt to equity

    1.26
    CTSO annual debt to equity ratio is 1.26

    Interest coverage ratio

    -15.02
    CTSO annual interest coverage ratio is -15.02

    Risk & Stability

    Piotroski F-Score

    3
    CTSO piotroski f-score is 3

    Altman Z-Score

    -8.27
    CTSO altman z-score is -8.27

    Analyst ratings

    Recent major analysts updates

    May 15, 25 HC Wainwright & Co.
    Neutral
    May 15, 25 D. Boral Capital
    Buy
    May 2, 25 D. Boral Capital
    Buy
    Apr 3, 25 HC Wainwright & Co.
    Neutral
    Apr 1, 25 D. Boral Capital
    Buy
    Feb 25, 25 D. Boral Capital
    Buy
    Jan 13, 25 D. Boral Capital
    Buy
    Jan 3, 25 D. Boral Capital
    Buy
    Nov 12, 24 D. Boral Capital
    Buy
    Nov 11, 24 HC Wainwright & Co.
    Neutral

    Institutional Ownership

    Screeners with CTSO included

    Growing Shares Outstanding
    US stocks
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Cytosorbents?
    • Does Cytosorbents pay dividends?
    • What sector is Cytosorbents in?
    • What industry is Cytosorbents in?
    • What country is Cytosorbents based in?
    • When did Cytosorbents go public?
    • Is Cytosorbents in the S&P 500?
    • Is Cytosorbents in the NASDAQ 100?
    • Is Cytosorbents in the Dow Jones?
    • When was Cytosorbents's last earnings report?
    • When does Cytosorbents report earnings?

    What is the ticker symbol for Cytosorbents?

    The ticker symbol for Cytosorbents is NASDAQ:CTSO

    Does Cytosorbents pay dividends?

    No, Cytosorbents does not pay dividends

    What sector is Cytosorbents in?

    Cytosorbents is in the Healthcare sector

    What industry is Cytosorbents in?

    Cytosorbents is in the Medical Devices industry

    What country is Cytosorbents based in?

    Cytosorbents is headquartered in United States

    When did Cytosorbents go public?

    Cytosorbents's initial public offering (IPO) was on August 8, 2006

    Is Cytosorbents in the S&P 500?

    No, Cytosorbents is not included in the S&P 500 index

    Is Cytosorbents in the NASDAQ 100?

    No, Cytosorbents is not included in the NASDAQ 100 index

    Is Cytosorbents in the Dow Jones?

    No, Cytosorbents is not included in the Dow Jones index

    When was Cytosorbents's last earnings report?

    Cytosorbents's most recent earnings report was on May 14, 2025

    When does Cytosorbents report earnings?

    The next expected earnings date for Cytosorbents is August 13, 2025
    On this page